FIGURE 3.

Myocardial T2 measurement of a COVID‐19 patient and a healthy control. A 36‐year‐old male infected with SARS‐CoV‐2 and positive virus nucleic acid test presented with a fever for 5 days before moving to the infection department. He had no preexisting cardiovascular disease; no cardiovascular symptoms; and no elevated myocardial enzyme, troponin, or brain natriuretic peptide during the whole course of COVID‐19. High‐sensitivity C‐reactive protein and D‐dimer were abnormally elevated at 46.57 mg/L (normal value 0.068–8.2 mg/L) and 423 ng/mL (normal value 0–243 ng/mL), respectively, and lymphocyte count was abnormally decreased at 0.68 × 109/L (normal value 1.1–3.2 × 109/L) during hospitalization. T2 map on day 51 after admission showed a significantly increased myocardial T2 value (54.9 msec) (a) compared to another 40‐year‐old male healthy control (47.5 msec) (b).